Fig. 2From: The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancerSurvival curves with the log-rank tests of overall survival (OS, a, p < 0.001) and breast cancer-specific survival (BCSS, b, p < 0.001) based on metastatic sites for breast cancer patientsBack to article page